APPL Share Price Today - Aptus Pharma on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
LG Electronics	1,656.30	#1 1,12,425.07	63.10	#1 24,932.80	1.23	#1 1,685	27.20	52.37
Voltas	1,142.10	37,790.35	84.66	14,482.60	-7.97	370	51.35	38.96
Blue Star	1,565.00	32,178.71	62.98	12,463.90	3.50	527	-15.15	55.80
Amber Enterprises	7,098.00	25,033.06	203.45	12,306.60	#1 22.50	227	-97.08	41.57
Crompton Greaves	225.05	14,491.30	-68.69	8,161.20	2.88	-231	15.17	35.64
V-Guard Industries	324.95	14,196.77	38.94	5,989.30	6.98	308	76.56	46.76
Whirlpool	723.65	9,181.08	36.20	8,233.40	1.52	295	-29.57	32.41
Eureka Forbes	378.45	7,319.95	41.22	2,732.80	11.47	163	47.29	25.56
TTK Prestige	524.90	7,188.56	38.27	3,040.90	8.96	157	#1 130.47	27.15
IFB Industries	1,222.30	4,952.61	#1 30.98	5,652.60	10.25	144	64.12	32.19

Annual Financials	2023	2024	2025	2026	TTM
Revenue	14	18	25	47	0
Expenses	13	16	20	39	0
EBITDA	1	2	5	8	0
Operating Profit %	4 %	9 %	20 %	16 %	0 %
Depreciation	0	0	0	0	0
Interest	0	0	1	1	0
Profit Before Tax	0	1	4	6	0
Tax	0	0	1	2	0
Net Profit	0	1	3	5	0
EPS in ₹	1.30	5.32	6.37	7.78	0.00

Balance Sheet	2023	2024	2025	2026
Total Assets	6	10	22	44
Fixed Assets	1	1	1	3
Current Assets	6	8	20	35
Capital Work in Progress	0	0	0	0
Investments	0	0	0	0
Other Assets	6	9	21	41
Total Equity & Liabilities	6	10	22	44
Current Liabilities	3	4	12	19
Non Current Liabilities	2	4	3	1
Total Equity	1	2	7	23
Reserve & Surplus	1	2	2	17
Share Capital	0	0	5	7

Cash Flow	2023	2024	2025	2026
Net Cash Flow	0	0	4	-4
Investing Activities	-0	-0	-1	-6
Operating Activities	-0	-2	-2	-6
Financing Activities	1	3	7	8

% Holding	Jun 2025	Sept 2025	Dec 2025	Mar 2026	May 2026	Jun 2026
Promoter	72.89 %	72.89 %	72.89 %	72.89 %	72.89 %	72.89 %
FIIs	10.03 %	10.03 %	0.00 %	0.00 %	0.00 %	0.00 %
DIIs	2.80 %	2.80 %	0.00 %	0.00 %	0.00 %	0.00 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	11.55 %	11.55 %	22.97 %	23.47 %	23.76 %	24.03 %
Others	2.74 %	2.74 %	4.14 %	3.64 %	3.35 %	3.08 %
No of Share Holders	9	9	302	337	356	686

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
10 Nov 2025	Quarterly Result Announcement	NA	10 Nov 2025	51.68	58.20
27 Apr 2026	Quarterly Result Announcement	NA	27 Apr 2026	151.58	144.20
12 May 2026	Bonus	3:2	12 May 2026	148.00	172.16
14 Sept 2026	Annual General Meeting	NA	14 Sept 2026	279.80	339.90

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Aptus Pharma

Company News

Peer Comparison Compare Peers on Screener

Yearly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Technical Indicators